![](/img/cover-not-exists.png)
NSCLC, early stageNeoadjuvant anti-PD1, nivolumab, in early stage resectable non-small-cell lung cancer
Forde, P.M., Smith, K.N., Chaft, J.E., Hellmann, M., Merghoub, T., Wolchok, J.D., Yang, S.C., Battafarano, R.J., Gabrielson, E., Georgiades, C.S., Verde, F., Rosner, G.L., Naidoo, J., Cottrell, T.R.,Volume:
27
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw435.38
Date:
October, 2016
File:
PDF, 38 KB
english, 2016